PeriVision registers virtual reality, AI eye testing platform with FDA
PeriVision announced FDA registration for its first medical software product, VisionOne, a cloud-based platform that uses portable virtual reality headsets and AI technology to help eye care providers configure eye tests and analyze results.
“We are thrilled to receive FDA registration for our latest medical device,” Ernest Cavin, MBA, PhD, vice president of international sales at Ziemer Ophthalmology and PeriVision board member, said in a company press release. “This milestone represents the culmination of years of research, development and collaboration with leading institutions. We are confident that this technology will significantly impact the way eye tests are performed, ultimately improving patient outcomes.”
According to the release, the VisionOne device uses AI, virtual reality and eye tracking to conduct more efficient visual field testing. AI algorithms optimize the tests, automate assistance and provide insight for clinical decision-making.
“We want to develop a holistic platform comprising a portfolio of eye tests and AI tools to assist ophthalmologists and optometrists in their daily work,” Kevin Gillmann, MD, PhD, MBBS, MBA, PeriVision’s chief medical officer, said in the release. “Our ultimate goal is to build software tools that improve patient experience, disease management and clinic productivity.”
Read more about